Intermediate cells harbor the expression of HEY1 and MYCL, with MYCL acting as an early driver of MCC differentiation and HEY1 functioning as an early repressor of the MCC fate specifically expressed in SC precursors. This evidence concerns the gene MYCL and Merkel cell skin cancer.